Literature DB >> 6103272

Captopril and agranulocytosis.

J Staessen, R Fagard, P Lijnen, A Amery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6103272     DOI: 10.1016/s0140-6736(80)90853-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

Review 1.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

2.  Hypertension. Current therapeutic practice reviewed.

Authors:  B N Prichard
Journal:  Drugs       Date:  1986       Impact factor: 9.546

3.  Reversible captopril-associated bone marrow aplasia.

Authors:  R K Strair; W E Mitch; D V Faller; K L Skorecki
Journal:  Can Med Assoc J       Date:  1985-02-15       Impact factor: 8.262

4.  Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.

Authors:  B C Campbell; A N Shepherd; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

5.  Captopril in various forms of severe therapy-resistant hypertension.

Authors:  A Studer; T Lüscher; W Siegenthaler; W Vetter
Journal:  Klin Wochenschr       Date:  1981-01-15

6.  Fatal bone-marrow suppression associated with captopril.

Authors:  A el-Makri; M S Larabi; C Kechrid; C Belkahia; H Ben Ayed
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-25

7.  Long-term captopril treatment in moderate to severe hypertension.

Authors:  A Santucci; F Aguglia; G De Mattia; C Ficara; F Balsano
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 8.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

9.  Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.

Authors:  K O Stumpe; A Overlack; R Kolloch; S Schreyer
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

10.  Captopril in severe childhood hypertension--reversible anaemia with high dosage.

Authors:  H A Verhaaren; J Vande Walle; A Devloo-Blancquaert
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.